Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide
Author:
Funder
Ministry of Healthcare of the Russian Federation
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00210-023-02940-5.pdf
Reference38 articles.
1. Abramochkin DV, Kuzmin VS, Rosenshtraukh LV (2015) Effects of new class III antiarrhythmic drug cavutilide on electrical activity in murine ventricular myocardium and their ionic mechanisms. Naunyn Schmiedebergs Arch Pharmacol 388:1105–1112. https://doi.org/10.1007/s00210-015-1146-x
2. Abramochkin DV, Karimova VM, Filatova TS, Kamkin A (2017) Diadenosine pentaphosphate affects electrical activity in guinea pig atrium via activation of potassium acetylcholine-dependent inward rectifier. J Physiol Sci 67:523–529. https://doi.org/10.1007/s12576-016-0510-z
3. Abramochkin DV, Kuzmin VS, Rosenshtraukh LV (2017) A new class III antiarrhythmic drug niferidil prolongs action potentials in guinea pig atrial myocardium via inhibition of rapid delayed rectifier. Cardiovasc Drugs Ther 31:525–533. https://doi.org/10.1007/s10557-017-6762-x
4. Abramochkin DV, Pustovit OB, Mironov NYu, Filatova TS, Kuzmin VS (2023) The dependence of the electrophysiological effects of class III antiarrhythmic drug refralon on the frequency of myocardium activation. Bull Exp Biol Med 174(5):610–615. https://doi.org/10.1007/s10517-023-05756-8
5. Bash LD, Buono JL, Davies GM, Martin A, Fahrbach K, Phatak H, Avetisyan R, Mwamburi M (2012) Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation. Cardiovasc Drugs Ther 26(2):167–179. https://doi.org/10.1007/s10557-012-6374-4
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3